Lovastatin prevents development of hypertension in spontaneously hypertensive rats

Hypertension

Volumn 30, Issue 4, 1997, Pages 968-974

  Jiang, Jian ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Hypertension; Hypertrophy; Lovastatin; Natriuresis; Rats, inbred SHR

Indexed keywords

HYDRALAZINE; MEVINOLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY MEDULLA; KIDNEY PERFUSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RENOVASCULAR DISEASE; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030809963     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.968     Document Type: Article

References (40)

1. MacMahon SW, MacDonald GL, Blacket RB. Plasma lipoprotein levels in treated and untreated hypertensive men and women: the National Heart Foundation of Australia Risk Factor Prevalence Study. Arteriosclerosis. 1985;5:391-396.
2. Laurenzim M, Mancini M, Menotti A, Stamler J, Stamler R, Trevisan M, Zanchetti A. Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens. 1990;8(suppl 20):7-12.
3. Reaven GM. Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med. 1991;90:7s-12s.
4. Donnelly R, Connell JMC. Insulin resistance: possible role in the etiology and clinical course of hypertension. Clin Sci. 1992;83: 265-275.
5. Williams RR, Hunt SC, Wu LL, Hopkins PN, Hasstedt SJ, Schumacher MC, Stults BM, Kuida H. Concordant dyslipidemia, hypertension, and early coronary disease in Utah families. Klin Wochenschr. 1990;68:52-58.
6. Williams RR, Hunt SC, Hopkins PN, Stults BM, Wu LL, Hasstedt SJ, Barlow GK, Stephenson SH, Lalouel JM, Kuida H. Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988;259:3579-3586.
7. Roman RJ, Ma YH, Frohlich B, Markham B. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension. 1993;21:985-988.
8. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension. 1992;20:651-658.
9. Roman RJ, Cowley AW Jr. Abnormal pressure-diuresis-natriuresis response in spontaneously hypertensive rats. Am J Physiol. 1985; 248:F199-F205.
10. Roman RJ, Kaldunski ML. Renal cortical and papillary blood flow in spontaneously hypertensive rats. Hypertension. 1988;11:657-663.
11. Lee RMKW, Forrest JB, Garfield RE, Daniel EE. Comparison of blood vessel wall dimensions in normotensive and hypertensive rats by histometric and morphometric methods. Blood Vessels. 1983;20: 245-254.
12. Furuyama M. Histometrical investigations of arteries in reference to arterial hypertension. Tohoku J Exp Med. 1962;76:388-414.
13. Fenoy FJ, Kauker ML, Milicic I, Roman RJ. Normalization of pressure-natriuresis by nisoldipine in spontaneously hypertensive rats. Hypertension. 1992;19:49-55.
14. Roman RJ, Cowley AW Jr, Garcia-Estan J, Lombard JH. Pressure-diuresis in volume-expanded rats: cortical and medullary hemodynamics. Hypertension. 1988;12:168-176.
15. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF. Pharmacological treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res. 1988;62: 367-374.
16. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int. 1988;33:667-672.
17. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med. 1985;106:598-604.
18. Habenicht AJR, Glomset JA, Ross R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem. 1980;255:5134-5140.
19. Soma MR, Donetti E, Parolinic C, Mazzini G, Ferrari C, Fumagalli R, Paoletti R. HMG-CoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb. 1993;13:571-578.
20. Kornbrust DJ, MacDonald JS, Peter CP, Duchai DM, Stubbs RJ, Germershausen JI, Alberts AW. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. J Pharmacol Exp Ther. 1989;248:498-505.
21. Lu SH, Mattson DL, Cowley AW Jr. Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats. Hypertension. 1994;23:337-345.
22. Lu SH. The Role of Renal Medullary Circulation in Long-term Control of Renal Function and Arterial Pressure in Spomaneously Hypertensive Rats. Milwaukee. Wise: Medical College of Wisconsin: 1995:117-124. Thesis.
23. Kline RL, MeLennan GP. Chronic hydralazine treatment alters the acute pressure-natriuresis curve in young spontaneously hypertensive rats. Can J Physiol Pharmacol. 1991;69:164-169.
24. Zou AP, Roman RJ. Influence of the renal medullary circulation on the control of sodium excretion. Am J Physiol. 1993;65:R963-R973.
25. Lee RMKW. Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats. Blood Vessels. 1985;22:105-126.
26. Eccleston-Joyner CA, Gray SD. Arterial hypertrophy in the fetal and neonatal spontaneously hypertensive rat. Hypertension, 1988; 12:513-518.
27. Adams M, Bobik A, Korner PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension: relation to sympathetic function. Hypertension. 1488;12:513-518.
28. Dilley RJ, Kanellakis P, Oddie CJ, Bobik A. Vascular hypertrophy in renal hypertensive spontaneously hypertensive rats. Hypertension. 1994;24:8-15.
29. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
30. Smeda JS, Lee RMKW, Forrest JB. Prenatal and postnatal hydralazine treatment does not prevent renal vessel wall thickening in SHR despite the absence of hypertension. Circ Res. 1988;63:534-542.
31. Smeda JS, Lee RMKW. Effect of hydralazine on the mesenteric vasculature of hypertensive rats. Hypertension. 1991;75:526-533.
32. Kett MM, Alcorn D, Bertram JF, Anderson WP. Enalapril does not prevent renal arterial hypertrophy in spontaneously hypertensive rats. Hypertension. 1995;25:335-342.
33. Feld LG, Liew JBV, Brentjens JR, Boylan JW. Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int. 1981;20:604-614.
34. Iritani N, Fukuda E, Nara Y, Yamori Y. Lipid metabolism in spontaneously hypertensive rats (SHR). Atherosclerosis. 1977;28: 217-222.
35. Clarke S. Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem. 1992;61:355-386.
36. Hall A. The cellular functions of small GTP-hinding proteins. Science. 1990;249:635-654.
37. Collin C, Parageorge AG, Lowy DR, Alkon DL. Early enhancement of calcium currents by H-ras oncoproteins injected into Hermissenda neurons. Science. 1990;250:1743-1745.
38. Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem. 1992;267:8719-8722.
39. 2+-responsiveness of smooth muscle contraction. FEBS Lett. 1993;324: 211-215.
40. 2+ responses in rat A10 vascular smooth muscle cells. Circ Res. 1994;74:173-181.